Cellosaurus MDA-MB-231 dCas9-VPR (CVCL_DX80)
Cell line name | MDA-MB-231 dCas9-VPR |
---|---|
Accession | CVCL_DX80 |
Resource Identification Initiative | To cite this cell line use: MDA-MB-231 dCas9-VPR (RRID:CVCL_DX80) |
Comments | Group: Triple negative breast cancer (TNBC) cell line. Population: Caucasian. Characteristics: Transduced with a lentiviral vector EF1a-Bsd-T2A-dCas9-VPR-WPRE, where VPR is a tripartite activation system made of a fusion of VP64, p65(relA), and RTA (Horizon_Discovery=HD+dCas9-VPR-014). Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9). Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd). Genetic integration: Method=Transduction; Gene=MGI; MGI:103290; Rela (Note=With p.Met1_Leu368 del). Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. |
Sequence variations |
|
Disease | Breast adenocarcinoma (NCIt: C5214) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_0062 (MDA-MB-231) |
Sex of cell | Female |
Age at sampling | 51Y |
Category | Cancer cell line |
Cross-references | |
Cell line collections (Providers) | Horizon_Discovery; HD+dCas9-VPR-014 |
Encyclopedic resources | Wikidata; Q127382752 |
Entry history | |
Entry creation | 30-Jan-2024 |
Last entry update | 10-Sep-2024 |
Version number | 2 |